Pharsight

Acerus patents expiration

1. Natesto patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784882 ACERUS Controlled release delivery system for nasal applications and method of treatment
Feb, 2024

(4 months from now)

US8877230 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(4 months from now)

US8574622 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(4 months from now)

US8784869 ACERUS Controlled release delivery system for nasal applications and methods of treatment
Feb, 2024

(4 months from now)

US11090312 ACERUS Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
Mar, 2034

(10 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 28 May, 2014

Treatment: A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation.; Nasal administrat...

Dosage: GEL, METERED;NASAL

More Information on Dosage

NATESTO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic